News &amp; Updates

In patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise, teneligliptin presents a safe and effective way of disease control, a recent study has found.

Teneligliptin a safe and effective treatment option for T2DM

Vitamin D may be protective in type 2 diabetes with lower extremity arterial disease

Patients with type 2 diabetes (T2D) with lower extremity arterial disease (LEAD) show low vitamin D levels, which increase the likelihood of stenosis and occlusion, especially in inferior genicular artery, a study has found.

Vitamin D may be protective in type 2 diabetes with lower extremity arterial disease

Erectile dysfunction in healthy men more likely related to depression than MetS

Erectile dysfunction is quite common among apparently healthy men, and this is more likely to be related to depressive symptoms rather than metabolic syndrome (MetS), a study has found.

Erectile dysfunction in healthy men more likely related to depression than MetS

Choline supplementation carries increased T2D risk in women but not in men

Women with high dietary choline intake risk developing type 2 diabetes (T2D), an association that is not observed in men, according to a study.

Choline supplementation carries increased T2D risk in women but not in men

Arterial stiffness tied to cardiorenal Injury in lateralized primary aldosteronism

03 Oct 2020

An association exists between preoperative severe arterial stiffness and absence of complete clinical success in lateralized primary aldosteronism (PA) patients following adrenalectomy, a study has found. Such effect may play a role in cardiorenal injury, which partially explains kidney function deterioration and reduced regression of heart mass.

Arterial stiffness tied to cardiorenal Injury in lateralized primary aldosteronism

03 Oct 2020

T2D effect on dementia varies by subtype

02 Oct 2020 by

Type 2 diabetes (T2D) may be associated with an elevated risk of dementia, but the effect varies according to dementia subtype, according to a study presented at EASD 2020.

T2D effect on dementia varies by subtype

02 Oct 2020

PTH predicts mortality in coronary angiography patients with T2DM

02 Oct 2020

Serum parathyroid hormone (PTH) shows a significant and robust all-cause mortality in coronary angiography patients with type 2 diabetes mellitus (T2DM) compared with those without, a recent study has shown.

PTH predicts mortality in coronary angiography patients with T2DM

02 Oct 2020

Preconception levothyroxine does not improve cognitive outcomes in children

Preconception treatment with levothyroxine fails to bring significantly better cognitive outcomes in children up to age 2 years compared with treatment initiated at 8–14 weeks of gestation, a study has found.

Preconception levothyroxine does not improve cognitive outcomes in children

No evidence to support incretins as neuroprotective in T2DM

There is not enough irrefutable evidence that dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists have positive effects on cognition in patients with type 2 diabetes mellitus (T2DM), according to a study.

No evidence to support incretins as neuroprotective in T2DM